The gemfibrozil cost-benefit model
Subtitle: analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population
By: Syam Sarma.
Series: Rand Graduate School dissertation -- RGSD-105; Dissertation (Rand Graduate School) -- RGSD-105.
Publisher: RAND
Published: 1993
Place of publication: Santa Monica, CA
Language: eng
Number of pages: 139
Subjects: Coronary heart disease -- Prevention -- Finland.; Coronary heart disease -- Treatment.; Gemfibrozil -- Therapeutic use; Medicaid -- California -- Cost effectiveness
Notes: Thesis (Ph. D.)--Rand Graduate School, 1991.

Includes bibliographical references (p. 127-139).